166 related articles for article (PubMed ID: 1304863)
1. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands.
Jerusalinsky D; Cerveñasky C; Peña C; Raskovsky S; Dajas F
Neurochem Int; 1992 Feb; 20(2):237-46. PubMed ID: 1304863
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions.
Jerusalinsky D; Kornisiuk E; Bernabeu R; Izquierdo I; Cerveñansky C
Toxicon; 1995 Apr; 33(4):389-97. PubMed ID: 7570625
[TBL] [Abstract][Full Text] [Related]
3. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors.
Kornisiuk E; Jerusalinsky D; Cerveñansky C; Harvey AL
Toxicon; 1995 Jan; 33(1):11-8. PubMed ID: 7778123
[TBL] [Abstract][Full Text] [Related]
4. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors.
Adem A; Asblom A; Johansson G; Mbugua PM; Karlsson E
Biochim Biophys Acta; 1988 Mar; 968(3):340-5. PubMed ID: 3345316
[TBL] [Abstract][Full Text] [Related]
5. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors.
Max SI; Liang JS; Potter LT
J Neurosci; 1993 Oct; 13(10):4293-300. PubMed ID: 8410188
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
7. A peptide muscarinic toxin from the Green Mamba venom shows agonist-like action in an inhibitory avoidance learning task.
Jerusalinsky D; Cerveñansky C; Walz R; Bianchin M; Izquierdo I
Eur J Pharmacol; 1993 Aug; 240(1):103-5. PubMed ID: 8405118
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
9. Anti-muscarinic toxins from Dendroaspis angusticeps.
Liang JS; Carsi-Gabrenas J; Krajewski JL; McCafferty JM; Purkerson SL; Santiago MP; Strauss WL; Valentine HH; Potter LT
Toxicon; 1996; 34(11-12):1257-67. PubMed ID: 9027981
[TBL] [Abstract][Full Text] [Related]
10. A snake toxin against muscarinic acetylcholine receptors: amino acid sequence, subtype specificity and effect on guinea-pig ileum.
Jolkkonen M; Adem A; Hellman U; Wernstedt C; Karlsson E
Toxicon; 1995 Apr; 33(4):399-410. PubMed ID: 7570626
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
12. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
13. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
14. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
Adem A; Sabbagh M; Nordberg A
J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of phosphatidylserine on the binding of muscarinic cholinergic receptor ligands. Studies in vitro and in vivo.
Raskovsky S; Rivas E; Bernik D; Medina J; Jerusalinsky D
Mol Chem Neuropathol; 1990; 13(1-2):17-32. PubMed ID: 2095782
[TBL] [Abstract][Full Text] [Related]
16. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
18. An approach to analysis of radiolabeled ligand interactions with specific receptors.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
